Question 36418 — pharmacy and medications

Summary

Ms. Fannette Charvier draws the attention of the Minister of Solidarity and Health to the cessation of manufacturing of the Medtronic implantable insulin pump. This pump makes it possible to carry out intra-peritoneal treatment, prescribed to several hundred people. The latter treats an atypical form of diabetes characterized by subcutaneous insulin resistance and this pump is the only one that can treat these people. However, Medtronic has decided to stop its production for economic reasons. There are two potential buyers, namely the Dutch company IPADIC and the American company Physiologic Devices, which are developing implantable pumps, but they have suspended their development due to lack of resources. This treatment being vital, she would like to know the actions that the ministry intends to take to provide solutions to this problem.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.